CSC’s acquisition of iSoft approved by European Commission

CSC’s acquisition of iSoft approved by European Commission

Only approval by shareholders and final Court assent left to realise deal

CSC’s (NYSE: CSC) acquisition of healthcare IT solutions provider, iSoft (ASX:ISF), has been granted unconditional clearance by the European Commission to go ahead.

Since the deal has received clearance by the Commission, all that remains to complete the transaction is gaining the approval of shareholders and final Court assent in Australia.

CSC originally acquired all of the outstanding equity of iSoft via a court-approved scheme of arrangement in April, but there were fears that the deal might get derailed following the commencement of legal proceedings by iSoft founder Gary Cohen against investor Oceania Capital Partners in the same month.

Once completed, the acquisition of iSoft is expected to bolster CSC’s existing range of software products, services portfolio, and healthcare research and development capabilities.

Follow Us

Join the newsletter!


Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.

Tags servicessoftwarecsciSOFTresearch and developmentOceania Capital PartnersIT solutions


ARN Innovation Awards 2022

Innovation Awards is the market-leading awards program for celebrating ecosystem innovation and excellence across the technology sector in Australia.

EDGE 2022

EDGE is the leading technology conference for business leaders in Australia and New Zealand, built on the foundations of collaboration, education and advancement.

Brand Post

Channel Roadmap

The Channel Roadmap is a bespoke content hub housing strategic priorities from technology vendors for 2022 and beyond, partners can find the guidance on the key technologies and markets to pursue, to help build a blueprint for future success.

Show Comments